Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (112)
2025 (1350)
2024 (1422)
2023 (1383)
2022 (1484)
2021 (1501)
2020 (1305)
2019 (1146)
2018 (1213)
2017 (1101)
2016 (996)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (20)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (15538)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Scarfò L
JSON
CSV
XLSX
TXT
Family name
Scarfò
Given name
Lydia
Initials
L
ORCID
ORCID
0000-0002-0844-0989
Affiliations
Università Vita-Salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy.
5 publications
PubMed
DOI
Crossref
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.
Visentin A
,
Gaffo E
,
Fürstenau M
, ...,
Trentin L
,
Bortoluzzi S
Leukemia
39
(12) 2957-2967 [2025-12-00; online 2025-09-19]
PubMed
DOI
Crossref
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.
Nadeu F
,
Shuai S
,
Clot G
, ...,
Puente XS
,
Campo E
Leukemia
39
(9) 2076-2086 [2025-09-00; online 2025-06-30]
PubMed
DOI
Crossref
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.
Hägerstrand D
,
Oder B
, Cortese D, ..., Sutton LA,
Rosenquist R
Leukemia
38
(11) 2429-2442 [2024-11-00; online 2024-09-11]
PubMed
DOI
Crossref
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Visentin A
,
Chatzikonstantinou T
,
Scarfò L
, ...,
Stamatopoulos K
,
Ghia P
Am. J. Hematol.
98
(12) 1856-1868 [2023-12-00; online 2023-09-29]
PubMed
DOI
Crossref
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.
Bonfiglio S
, Sutton LA, Ljungström V, ...,
Rosenquist R
,
Ghia P
Blood Adv
7
(12) 2794-2806 [2023-06-27; online 2023-01-26]
SciLifeLab Data Centre
Publications
9.5.1